STOCK TITAN

Quoin Pharmaceuticals: Millennium reports 4.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Quoin Pharmaceuticals Ltd. (QNRX) is the issuer in an amended ownership disclosure naming Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. Each reports beneficial ownership of 8,396,903 ordinary shares, or 4.99%, with shared voting and dispositive power and zero sole voting or dispositive power. The same position is reported for each person, not four separate holdings.

The disclosure says the securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC and Israel A. Englander. It also states that the report should not itself be construed as an admission of beneficial ownership by those three.

Beneficially owned ordinary shares 8,396,903 shares Reported by each of the four persons, with shared voting and dispositive power
Percent of class 4.99% Reported by each reporting person
ADS ratio 35 ordinary shares per American Depositary Share Ratio stated for the issuer's American Depositary Shares
beneficially owned regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 8,396,903.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Rule 13d-3(d)(1)(i) regulatory
"as provided in Rule 13d-3(d)(1)(i)"
American Depositary Shares financial
"assigned to the issuer's American Depositary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QNRX ordinary shares did each reporting person report?

Each of the four reporting persons reported beneficial ownership of 8,396,903 ordinary shares, or 4.99%, with shared voting and dispositive power. The same position appears under each reporting person.

How many ordinary shares does one QNRX American Depositary Share represent?

Each American Depositary Share represents 35 ordinary shares.

How is the reported 4.99% ownership calculated?

The calculation gives effect to shares deemed outstanding under Rule 13d-3(d)(1)(i), presuming warrants held or controlled by a reporting person are exercisable within 60 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





74907L409

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:11/13/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:11/13/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:11/13/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:11/13/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner CUSIP number 74907L409 has been assigned to the issuer's American Depositary Shares. Each American Depositary Share represents thirty-five Ordinary Shares. No CUSIP number has been assigned to the issuer's Ordinary Shares.
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of November 13, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

Keep reading